← Leaderboards
Vaughn Vasil Smider
Integrigen, Inc.
$9,548,114
Attributed
$10,405,472
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,405,472 · 9
By mechanism
R01$7,685,518 · 3
R21$1,519,956 · 3
RC1$999,998 · 1
R43$200,000 · 2
Top collaborators
- Brunhilde Felding-Habermann2 shared
- Peter G Schultz2 shared
- John Ross Teijaro2 shared
Others in their field
Top investigators on “Cattle”
- Mikael Knip · University Of Helsinki$18,419,936
- Christian Tschudi · Yale University$14,019,967
- Dorothy J Becker · Children'S Hosp Pittsburgh/Upmc Hlth Sys$13,640,541
- Glenn C Telling · Colorado State University$12,371,137
- Claudio Soto · University Of Texas Medical Br Galveston$11,707,011
- Elisabetta Ullu · Yale University$8,520,135
Research focus
CattleAntigensAntibodiesProteinsPropertyDisulfide BondAmino AcidsBindingStructureEpitopesMolecularLengthEngineeringNeutralizing AntibodySurfaceImmunizeMutagenesisDiagnosticViralPositioning AttributeCysteinePolysaccharidesAntigen BindingDeep Sequencing
Grant awards (27)
Broadly neutralizing SARS-CoV-2 peptidic knobs$921,025
R01 · FY2025 · AI · contact PI
Broadly neutralizing SARS-CoV-2 peptidic knobs$921,025
R01 · FY2024 · AI · contact PI
Broadly neutralizing SARS-CoV-2 peptidic knobs$967,225
R01 · FY2023 · AI · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$399,418
R01 · FY2021 · GM · contact PI
Defining clinically relevant viral epitopes with cow antibodies$352,893
R01 · FY2021 · HD · contact PI
Ultralong CDR3 antibodies targeting exhausted T cells$234,525
R21 · FY2021 · AI · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$399,418
R01 · FY2020 · GM · contact PI
Defining clinically relevant viral epitopes with cow antibodies$358,581
R01 · FY2020 · HD · contact PI
Ultralong CDR3 antibodies targeting exhausted T cells$303,450
R21 · FY2020 · AI · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$385,820
R01 · FY2019 · GM · contact PI
Defining clinically relevant viral epitopes with cow antibodies$359,955
R01 · FY2019 · HD · contact PI
Defining clinically relevant viral epitopes with cow antibodies$360,258
R01 · FY2018 · HD · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$290,737
R01 · FY2018 · GM · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$137,718
R01 · FY2018 · GM · contact PI
Defining clinically relevant viral epitopes with cow antibodies$379,845
R01 · FY2017 · HD · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$365,750
R01 · FY2017 · GM · contact PI
Cow ultralong CDR3 antibodies targeting HIV gp120$227,285
R21 · FY2017 · AI · contact PI
Molecular and Structural Studies of Antibody Diversity Mechanisms$365,750
R01 · FY2016 · GM · contact PI
Cow ultralong CDR3 antibodies targeting HIV gp120$298,054
R21 · FY2016 · AI · contact PI
Antibody Fingerprinting of Triple Negative Breast Cancer by High Throughput FACS$209,344
R21 · FY2016 · CA
Molecular and Structural Studies of Antibody Diversity Mechanisms$360,050
R01 · FY2015 · GM · contact PI
Antibody Fingerprinting of Triple Negative Breast Cancer by High Throughput FACS$247,298
R21 · FY2015 · CA
Molecular and Structural Studies of Antibody Diversity Mechanisms$360,050
R01 · FY2014 · GM · contact PI
Modular immunoconjugates$499,999
RC1 · FY2010 · EB · contact PI
Modular immunoconjugates$499,999
RC1 · FY2009 · EB · contact PI
ANTI-CANCER PROTEOLYTIC ANTIBODIES$100,000
R43 · FY2004 · CA
EVOLUTION OF ANTIMETASTATIC ENZYME$100,000
R43 · FY2002 · CA